Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3815 Target Snapshot

Squalene synthase · SINGLE PROTEIN · Rattus norvegicus

737Compounds
101Assays
1Approved Drugs
771.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q02769. Use UniProt Q02769 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q02769 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Squalene synthase as ChEMBL target CHEMBL3815, mapped to UniProt Q02769. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Squalene synthase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3815
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q02769
Squalene synthase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Squalene synthase is the right protein anchor across sources, using UniProt Q02769 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSqualene synthase
UniProt AccessionQ02769
Component TypeProtein
Sequence Length416 aa

Squalene synthase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Squalene synthase, mapped to UniProt Q02769. Sequence length is 416 aa.

Mapped IDQ02769
Review nameSqualene synthase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50743.0
KI28.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL335394 10.4 IC50 0.04 Preclinical
CHEMBL441322 10.4 IC50 0.04 Preclinical
CHEMBL505374 10.35 Ki 0.045 Preclinical
CHEMBL134337 10.3 IC50 0.05 Preclinical
CHEMBL131147 10.22 IC50 0.06 Preclinical
CHEMBL336939 10.15 IC50 0.07 Preclinical
CHEMBL40991 10.11 Ki 0.078 Preclinical
CHEMBL414430 10.05 IC50 0.09 Preclinical
CHEMBL436588 9.92 IC50 0.12 Preclinical
CHEMBL131335 9.89 IC50 0.13 Preclinical
Distribution

pChEMBL Value Distribution

59
5.0
37
5.5
46
6.0
62
6.5
67
7.0
93
7.5
85
8.0
54
8.5
34
9.0
17
9.5
pChEMBL
Approved Drugs

Approved Drugs

IBANDRONIC ACID
CHEMBL997
Approved 1996
Assay Landscape

Assay Landscape

101
Total Assays
623
Tested Compounds
2
Assay Types
Binding — 99 assays, 623 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 48 329 7.2
microsome format 23 119 6.1
single protein format 17 106 7.0
organism-based format 5 0
tissue-based format 5 27 6.7
cell-based format 1 42 8.6
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine